Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Patent
1987-06-18
1989-08-15
Hazel, Blondel
Drug, bio-affecting and body treating compositions
Lymphokine
Interleukin
424 856, 424 857, 514 44, A61K 4502, A61K 3170
Patent
active
048573159
ABSTRACT:
The invention relates to compositions containing an inhibitor of the Golgi enzyme .alpha.-mannosidase II and which may contain an interferon or interferon inducer and to methods of preventing and treating diseases, such as proliferative diseases, viral infections and neoplastic growth and metastasis with the compositions.
REFERENCES:
Humphries et al., Proc. Natl. Acad. Sci., vol. 83, pp. 1752-1756, Mar. 1986.
Goldstein et al., Cancer Research, vol. 46, pp. 4315-4329, 1986.
Chemical Abstracts, vol. 101, Abstract No. 28283x, 1984.
Chemical Abstracts, vol. 103, Abstract No. 81429s, 1985.
Nicolson, G. L., Biochem. Biophys. Acta. 695:113, 1982.
Poste, G. and Fidler, I. J., Nature 283:139, 1980.
Weiss, L., Semin. Oncl. 4:5-19, 1977.
Dennis, J. W. et al., Nature 292:242, 1981.
"Asparagine-Linked Oligosaccharides in Murine Tumor Cells: Comparison of a WGA-Resistant Nonmetastatic Mutant and a Related WGA-Sensitive Metastatic Line", Dennis, J. W. et al., J. Cell Biol. 99:1034, 1984.
"Partial Reversion of the Metastatic Phenotypes in a WGA Resistant Mutant of MDAY-D2 Selected with Bandeiraea Simplicifolia Seed Lectin BSII", Dennis, J. W., J. Natl. Cancer Inst. 74:1111, 1985.
Takasai, S. et al., Biochem. Biophys. Res. Commun. 92:735-742, 1980.
Yogeswarren, G., and Salk, P. L., Science (Wash. D.C.), 1514-1516, 1981.
Finne, J. et al., Cancer Res., 40:2580-2587, 1980.
Dennis et al., J. Cell. Biol. 99:1034-1044, 1984.
Yamashita K. et al., J. Biol. Chem. 259, 10834, 1984.
"Studies of an Immunomodulator, Swainsonine, I. Enhancement of Immune Response by Swainsonine In Vitro", Motohiro, Hino, et al., J. Antibiotics. 926-940, Jul. 1985.
Crisuodo, B. A., and Krag, S. S., J. Cell Biol. 94:586-591, 1982.
Zullo, Z. N. et al., Cell 43:783, 1985.
Lin, S. L. et al., Science 233:356-358, 1986.
Morin, M. J. et al., Can. Res. 43:1669-1674, 1983.
Einat, M. et al., Nature 313, 597, 1985.
Lau, L. F., and Nathans, D., Proc. Natl. Acad. Sci. U.S.A., 84, 1182, 1987.
Whitfield, J. F. et al., Cancer and Metastasis Reviews, 5, 205, 1987.
Goldstein, D., and Lasglo, J., Can. Res. 64:4315, 1986.
Levine, A. S. et al., Can. Res. 39:1645-1650, 1970.
Hunter, T., Nature 322:14-16, 1986.
Moheshwari, R. K. et al., Science 219:1339-1341, 1983.
Tulsiani, D. R. P. et al., J. Biol. Chem. 258:7578, 1983.
Pierce M. and Arango J., J. Biol. Chem. 261, 10772, 1986.
Debray H. et al., Int. J. Cancer 37, 607, 1986.
Dennis, J. W. et al., Science, 236:582, 1987.
Kerbel, R. S. et al., Proc. Natl Acad. Sci., U.S.A., 84, 1263, 1987.
Molyneux, R. J. and James, L. F., Science (Wash. D.C.) 216:190-191, 1981.
"Swainsonine Inhibits the Biosynthesis of Complex Glycoproteins by Inhibition of Golgi Mannosidase II", Tulsiani, D. R. P. et al., J. Biol. Chem. 257:7936-7939, 1982.
Tulsiani, D. R. P. and Touster, O., J. Biol. Chem. 260:13081-13087, 1985.
"The Similar Effects of Swainsonine and Locoweed on Tissue Alycosidases and Oligosaccharides of the Pig Indicate that the Alkaloid is the Principal Toxin Responsible for the Induction of Locoism", Tulsiani, D. R. P., et al., Arch. Biochem. Biophys., 232:76-85, 1984.
"Oligosaccharide Modification by Swainsonine Treatment Inhibits Pulmonary Colonization by B16-F10 Murine Melanoma Cells", Humphries, M. J. et al., Proc. Natl. Acad. Sci, U.S.A., 83:1752-2756, 1986.
Keller, R. K. et al., Biochem. 18:3946-3952, 1979.
Irimura et al., Cancer Res. 41:3411-3418, 1981.
Gibson, R. et al., Trends in Biochem. Sci. Nov. 290-293, 1980.
Hazel Blondel
Mount Sinai Hospital Corporation
LandOfFree
Compositions containing golgi alpha-mannosidase II inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions containing golgi alpha-mannosidase II inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions containing golgi alpha-mannosidase II inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-120331